BioTech Frontier Digest

Oral peptide approvals signal real progress, starting with semaglutide (Rybelsus) in 2019 for type 2 diabetes.

GLP-1 medications are peptide...

Two bioengineering strategies are advancing therapeutic applications by tackling dynamic challenges in living systems.

• Real-time synthetic control:...

Achieving an optimal balance between peptide hydrophobicity and cationicity drives effective antimicrobial action and targeted cell death in...

• Lp(a) standout: Nicotinic acid remains the only nutrient with consistent clinical evidence for supporting healthy Lp(a) metabolism via hepatic...

Effective topical GHK-Cu use centers on concentration, placement, and smart layering.

• Begin at 0.05-0.2% and titrate upward; higher percentages (up...

Peptide therapeutics are expanding beyond general anti-aging into precise interventions for pancreatic disorders and cardiac protection.

• Pancreatic...

• NAD+ delivers direct support but faces absorption challenges from its large, unstable molecule, favoring IV, liposomal or sublingual formats.
• NMN...

Therapeutic peptides offer a promising route to modulate cardiovascular aging by targeting the senescence-associated secretory phenotype, thanks to their physiological mechanisms and low side effect rates.

Biological truths are noisy, context-dependent, and shaped by factors like epistasis, unlike verifiable mathematical proofs, making AI integration...

Peptides demonstrate expanding versatility through targeted signaling across hormone, neurological, and cosmetic domains.

• TRT support: Kisspeptin...

The European Commission is advancing AI in life sciences via its AI in Science Strategy and Apply AI Strategy, focusing on molecular and cellular...

A daily multivitamin slowed biological aging by 4 months across all five aging clocks, highlighting how this accessible intervention may work through gut microbiome modulation for longevity gains.

Unregulated peptides carry dual risks: thin human data and plausible carcinogenic pathways.

• Evidence gap: BPC-157 and similar compounds lack...

TB-500 is the short acetylated fragment Ac-LKKTETQ (residues 17–23), not the complete 43-amino-acid thymosin beta-4.

• Human studies examined only...

Hims and Hers plans to sell sermorelin, glutathione, and NAD+ for anti-aging and wellness by year-end, riding strong consumer demand despite lacking...

NAD+ injections rest on solid biochemistry—restoring a coenzyme that powers mitochondria, sirtuins, and DNA repair—but large trials proving real-world...

Orthopedic groups see intriguing animal data for BPC-157 but stress the lack of strong human trials confirming real patient benefits.

• FDA's 2026...

Peptide therapies are expanding across longevity applications, with GHK-Cu targeting skin aging and cognitive peptides addressing brain decline.

-...

Decode Age has turned its December $1.7M raise into the March launch of Mag7—a seven-form magnesium supplement delivering 370mg elemental...

Peptide therapies show targeted promise but expose a stark divide between regulated evidence and dangerous hype.

• Menopause context: GLP-1 agonists...